Large-Scale, Comprehensive Quality Control and Analysis of High-Throughput Screening Data

By Dr Colin J Hardy, Director of Inhalation Studies at Huntingdon Life Sciences

Swen Reimann has a degree in Engineering from the Polytechnicum Winterthur, Switzerland and Hoogeschool Limburg, The Netherlands, as well as a business degree from the University of California Berkeley Extension. He has worked for two leading US software companies in sales and marketing positions prior to joining Genedata in 2001, where he currently serves as a Marketing and Sales Manager for Screener, Genedata's software suite for the scientific analysis of high-throughput screening data.

Michael Lindemann obtained a PhD in Physics from the University of Kiel for his work on multivariate time series analysis applied to human motor control. Previous to this he obtained a MSc from Michigan State University. Dr Lindemann acted as a consultant and IT trainer for several companies prior to joining Genedata in 2001 where he currently serves as Product Manager for Screener.

Bernd Rinn obtained a PhD in Physics from the University of Konstanz for his work on transport and physical ageing in disordered systems. During his studies Dr Rinn gained experience in building and maintaining IT systems for scientific computing and business applications. He joined Genedata in 2001 where he helped in designing and building the Screener system. Currently he leads the development of Screener with a focus on software architecture and algorithms.

Olivier Lefèvre obtained a PhD in Physics from the University of Paris VI for work on neural network models. Prior to this he studied molecular biology and biophysics. For the last eight years he has been working as a software developer, first at NYU Medical School and then at UBS Warburg. He joined GeneData in 2001 where he designed and wrote the AssayAnalyzer module of Screener.

Stephan Heyse earned his PhD in Biophysics from the Swiss Federal Institute of Technology in 1997 for his investigation of functionally active G protein-coupled receptors embedded in supported lipid membranes. He gained practical experience in pharmaceutical high-throughput screening at Bayer AG (Germany), where he headed a screening laboratory. Dr Heyse manages the scientific and technical development of Screener.